Condition: Primary Sclerosing Cholangitis · Sponsor: University of Milano Bicocca
Primary sclerosing cholangitis (PSC) a rare, chronic fibroinflammatory disease of the liver. No data about the disease epidemiology exist in Italy. Therefore this study aims to develop a national PSC patient database linked to a biological sample storage.
This description comes directly from the study's public registry record.
Pietro Invernizzi, MD · 039 233 2187 · pietro.invernizzi@unimib.it
Marco Carbone, MD · 02 6448 8139 · marco.carbone@unimib.it
Always discuss trial participation with your own doctor first.
| Ospedali riuniti di Ancona | Ancona, Italy | Not Yet Recruiting |
| Policlinico di Bari | Bari, Italy | Not Yet Recruiting |
| ASST Bergamo ovest | Bergamo, Italy | Not Yet Recruiting |
| ASST Papa Giovanni XXIII | Bergamo, Italy | Not Yet Recruiting |
| Ospedale Sant'Orsola Malpighi | Bologna, Italy | Not Yet Recruiting |
| Policlinico S. Orsola Malpighi | Bologna, Italy | Not Yet Recruiting |
| Azienda sanitaria dell'Alto Adige | Bolzano, Italy | Not Yet Recruiting |
| Spedali civili | Brescia, Italy | Not Yet Recruiting |
| Unità epatologica ed ecografia internistica a valenza dipartimentale, Fondazione Ospedaliera Poliambulanza | Brescia, Italy | Not Yet Recruiting |
| Policlinico universitario Monserrato | Cagliari, Italy | Not Yet Recruiting |
| Presidio Ospedaliero San Michele ARNAS G. Brotzu | Cagliari, Italy | Not Yet Recruiting |
| Osp. "S de Bellis" - IRCCS | Castellana Grotte, Italy | Not Yet Recruiting |
+ 51 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05618145